Paper3977675
Contrast sensitivity in diabetics with and without background retinopathy.
Sokol S and 5 others. Arch Ophthalmol, 1985. Cited by 251 papers, by iCite.
Cite this record
ConductScience Library. Contrast sensitivity in diabetics with and without background retinopathy. Papers, record 3977675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3977675
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Diabetic Retinopathy | Major topic |
| Visual Acuity | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Diabetes Mellitus, Type 1 | |
| Diabetes Mellitus, Type 2 | |
| Humans | |
| Middle Aged | |
| Sensory Thresholds |
Source PubMed
Cited by121
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 251 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41993457 | Mitochondrial Transplantation in the Eye: A Review and Evaluation of Surgical Approaches. | bioRxiv | 2026 | https://conductscience.org/library/papers/41993457 | PubMed |
| 41182028 | The Association of Retinal Capillary Density and Retinal Thickness in Diabetic Retinopathy. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/41182028 | PubMed |
| 40266592 | Structure-Function Associations Between Quantitative Contrast Sensitivity Function And Peripapillary Optical Coherence Tomography Angiography in Diabetic Retinopathy. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40266592 | PubMed |
| 40131295 | Neuronal Degeneration and Glial Activation in the Absence of Vascular Changes in Human Retinas of Patients With Diabetes. | Invest Ophthalmol Vis Sci | 2025 | https://conductscience.org/library/papers/40131295 | PubMed |
| 39768141 | SMOX Inhibition Preserved Visual Acuity, Contrast Sensitivity, and Retinal Function and Reduced Neuro-Glial Injury in Mice During Prolonged Diabetes. | Cells | 2024 | https://conductscience.org/library/papers/39768141 | PubMed |
| 39400905 | The relationship between ON-OFF function and OCT structural and angiographic parameters in early diabetic retinal disease. | Ophthalmic Physiol Opt | 2025 | https://conductscience.org/library/papers/39400905 | PubMed |
| 38881606 | Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures. | Ophthalmol Sci | 2024 | https://conductscience.org/library/papers/38881606 | PubMed |
| 38514075 | Association between vision impairment and increased prevalence of falls in older US adults. | J Am Geriatr Soc | 2024 | https://conductscience.org/library/papers/38514075 | PubMed |
| 38347052 | Electrophysiological findings in long-term type 1 diabetes patients without diabetic retinopathy using different ERG recording systems. | Sci Rep | 2024 | https://conductscience.org/library/papers/38347052 | PubMed |
| 37955700 | Associations of quantitative contrast sensitivity with wide-field swept-source optical coherence tomography angiography in retinal vein occlusion. | Graefes Arch Clin Exp Ophthalmol | 2024 | https://conductscience.org/library/papers/37955700 | PubMed |
| 37621091 | Improved Intermediate Visual Function with New Monofocal Intraocular Lens in Combined Cataract and Vitrectomy Surgery for Retinal Disease. | Korean J Ophthalmol | 2023 | https://conductscience.org/library/papers/37621091 | PubMed |
| 37278906 | Structure-function associations between contrast sensitivity and widefield swept-source optical coherence tomography angiography in diabetic macular edema. | Graefes Arch Clin Exp Ophthalmol | 2023 | https://conductscience.org/library/papers/37278906 | PubMed |
| 37174742 | Retinal Cell Damage in Diabetic Retinopathy. | Cells | 2023 | https://conductscience.org/library/papers/37174742 | PubMed |
| 37083950 | Contrast Increment and Decrement Processing in Individuals With and Without Diabetes. | Invest Ophthalmol Vis Sci | 2023 | https://conductscience.org/library/papers/37083950 | PubMed |
| 36699020 | Diabetic retinopathy: Looking forward to 2030. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/36699020 | PubMed |
| 36579516 | Speckle Contrast as Retinal Tissue Integrity Biomarker in Patients with Type 1 Diabetes Mellitus with No Retinopathy. | J Pers Med | 2022 | https://conductscience.org/library/papers/36579516 | PubMed |
| 36140415 | Choroidal and Retinal Thicknesses in Type 2 Diabetes Mellitus with Moderate Diabetic Retinopathy Measured by Swept Source OCT. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140415 | PubMed |
| 36139394 | Proteomic Analysis of Retinal Mitochondria-Associated ER Membranes Identified Novel Proteins of Retinal Degeneration in Long-Term Diabetes. | Cells | 2022 | https://conductscience.org/library/papers/36139394 | PubMed |
| 35616273 | Retinal neural dysfunction in diabetes revealed with handheld chromatic pupillometry. | Clin Exp Ophthalmol | 2022 | https://conductscience.org/library/papers/35616273 | PubMed |
| 35607958 | Biochemical mechanism underlying the pathogenesis of diabetic retinopathy and other diabetic complications in humans: the methanol-formaldehyde-formic acid hypothesis. | Acta Biochim Biophys Sin (Shanghai) | 2022 | https://conductscience.org/library/papers/35607958 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3977675
GET https://conductscience.org/api/papers/v1/3977675/cited_by?page=2